Literature DB >> 8381469

A novel cis-stimulatory element maps to the 5' portion of the human papillomavirus type 18 upstream regulatory region and is functionally dependent on a sequence-aberrant Sp1 binding site.

F Hoppe-Seyler1, K Butz.   

Abstract

Gene expression of the cancer-associated human papillomavirus (HPV) type 18 is modulated by cis-regulatory elements located within the viral upstream regulatory region (URR). All cellular factors identified so far involved in viral gene control bind to the 3' portion of the HPV-18 URR. In contrast, very little is known about regulatory elements within the 5' portion of the URR. We therefore analysed this region of unknown function to delineate potential cis-regulatory elements contained therein. By utilizing transient expression assays, an 84 bp fragment could be identified in the 5' portion of the URR that exhibits orientation-independent cis-stimulatory activity in HeLa cervical carcinoma cells and primary human fibroblasts. Gel retardation assays and competition experiments indicated specific binding of cellular proteins to the 84 bp fragment. By functional dissection, a regulatory element with intrinsic cis-stimulatory activity could be mapped within the 84 bp fragment. Binding studies indicate that this cis-stimulatory element contains a sequence-aberrant Sp1 recognition site. Transient luciferase assays performed with mutated templates demonstrate that this Sp1 binding site behaves as a functional Sp1 element in vivo and is a main determinant of the cis-stimulatory activity exerted by the 84 bp fragment. These data show that the 5' portion of the HPV-18 URR contains cis-activating elements and indicate an important functional role for the cellular transcription factor Sp1 in their regulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381469     DOI: 10.1099/0022-1317-74-2-281

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Genetic analysis of cis regulatory elements within the 5' region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle.

Authors:  Ellora Sen; Jennifer L Bromberg-White; Craig Meyers
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  CCAAT displacement protein, a regulator of differentiation-specific gene expression, binds a negative regulatory element within the 5' end of the human papillomavirus type 6 long control region.

Authors:  S Pattison; D G Skalnik; A Roman
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA.

Authors:  W Stünkel; Z Huang; S H Tan; M J O'Connor; H U Bernard
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification.

Authors:  Kathryn M Spink; Laimonis A Laimins
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/skn-1a.

Authors:  K Yukawa; K Butz; T Yasui; H Kikutani; F Hoppe-Seyler
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

6.  Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.

Authors:  K Butz; F Hoppe-Seyler
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

7.  Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters.

Authors:  M Hörer; S Weger; K Butz; F Hoppe-Seyler; C Geisen; J A Kleinschmidt
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

Review 8.  Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus.

Authors:  Natália Lourenço de Freitas; Maria Gabriela Deberaldini; Diana Gomes; Aline Renata Pavan; Ângela Sousa; Jean Leandro Dos Santos; Christiane P Soares
Journal:  Front Cell Dev Biol       Date:  2021-01-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.